levodopa has been researched along with Central Nervous System Cysticercosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sá, DS; Teive, HA; Troiano, AR; Werneck, LC | 1 |
| Bermejo, PG; Espiga, PJ; López, IC; Tapia, DQ | 1 |
| Netravathi, M; Pal, PK; Panda, S; Prashantha, DK; Ravishankar, S | 1 |
1 trial(s) available for levodopa and Central Nervous System Cysticercosis
| Article | Year |
|---|---|
Parkinsonism associated with neurocysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Antiparkinson Agents; Brain; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Neurocysticercosis; Parkinson Disease | 2005 |
2 other study(ies) available for levodopa and Central Nervous System Cysticercosis
| Article | Year |
|---|---|
[L-dopa sensitive Parkinsonism in neurocysticercosis].
Topics: Adult; Anthelmintics; Cerebrospinal Fluid Pressure; Female; Fourth Ventricle; Humans; Hydrocephalus; Levodopa; Neurocysticercosis; Parkinsonian Disorders; Ventriculoperitoneal Shunt | 2008 |
Reversible parkinsonism following ventriculoperitoneal shunt in a patient with obstructive hydrocephalus secondary to intraventricular neurocysticercosis.
Topics: Adult; Antiparkinson Agents; Cerebral Ventricles; Humans; Hydrocephalus; Levodopa; Male; Neurocysticercosis; Parkinsonian Disorders; Ventriculoperitoneal Shunt | 2008 |